NCT01195779View on ClinicalTrials.gov

Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children

PHASE2TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

March 22, 2011

Study Completion Date

March 22, 2011

Conditions
InfluenzaInfluenza Vaccines
Interventions
BIOLOGICAL

GSK Bio's influenza vaccine GSK2584786A, different formulations

Intramuscular injections

BIOLOGICAL

GSK Bio's influenza vaccine GSK2321138A

Intramuscular injections

BIOLOGICAL

Fluarix™

Intramuscular injections

Trial Locations (1)

41013

GSK Investigational Site, Seville

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01195779 - Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children | Biotech Hunter | Biotech Hunter